Recent Updates
Recently added Catalysts
LNTH Positive Sentiment Score: 70/100

Lantheus to Present at the Jefferies London Healthcare Conference

Wednesday, November 8, 2023 1 min read
Key Takeaway: Lantheus Holdings, Inc. announced that its President and CFO will present at the Jefferies London Healthcare Conference on November 15. This event underscores the company's focus on radiopharmaceuticals and their commitment to enhancing patient outcomes. The presentation indicates Lantheus's proactive approach in engaging with the investment community and highlighting its advancements in medicine.

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is committed to delivering better patient outcomes.
  • The company has over 65 years of experience in radiopharmaceutical solutions.
  • The upcoming presentation at a prominent healthcare conference highlights its visibility and engagement in the industry.

Full Press Release Details

BEDFORD, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes,, today announced Paul Blanchfield, President, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies London Healthcare Conference at 8:00 a.m. GMT (3 a.m. EST) on Wednesday, November 15.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Vice President, Investor Relations
Senior Director, External Communications

Frequently Asked Questions

When will Lantheus present at the Jefferies London Healthcare Conference?

Lantheus will present on November 15 at 8:00 a.m. GMT (3 a.m. EST).

How can I access the live presentation from Lantheus?

You can access the live webcast in the Investors section on Lantheus' website.

How long will the webcast replay be available?

The replay of the webcast will be accessible for at least 30 days post-presentation.

What is Lantheus focused on?

Lantheus specializes in radiopharmaceuticals to improve patient outcomes.

Where is Lantheus located?

Lantheus is headquartered in Massachusetts, with offices in New Jersey, Canada, and Sweden.

Tags: LNTH Viatris Investor Conferences Healthcare Lantheus radiopharmaceuticals Jefferies Conference healthcare
Last updated: Nov 8, 2023